Quanterix
Logotype for Quanterix Corporation

Quanterix (QTRX) investor relations material

Quanterix Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Quanterix Corporation
Q3 2026 earnings summary9 Nov, 2026

Executive summary

  • Q3 revenue was $34.974M, up 6.3% sequentially but down 13.1% YoY; management characterized the quarter as an initial step toward restoring growth.

  • Commercial and product strategy changes began supporting Q3 revenue; management expects improvement in Q4 and continued growth in 2027.

  • LucentAD test volume more than doubled sequentially, spatial consumables neared a record, and Accelerator Lab bookings rose for a second consecutive quarter.

Financial highlights

  • Q3 revenue was $34.974M versus $40.233M in Q3 2025; adjusted pro forma decline was 8.6%, excluding $2.4M from a terminated program and adding $0.6M of Akoya pre-acquisition revenue to the comparison.

  • Nine-month revenue rose 10% to $104.3M from $95.0M; product revenue increased 16% to $74.1M, while service and other revenue declined 4% to $28.8M.

  • Q3 GAAP gross profit was $13.5M; non-GAAP gross profit was $16.6M. GAAP operating loss was $22.5M versus $37.3M, and adjusted operating loss was $18.9M versus $19.8M.

  • Net loss was $21.6M versus $33.5M; adjusted EBITDA loss was $12.2M versus $11.9M.

  • Non-GAAP operating expenses were $35.4M, down $2.8M YoY and up $3.7M QoQ, including a one-time compensation timing impact; GAAP operating expenses were $36.0M, down $27.2M YoY.

Outlook and guidance

  • FY2026 revenue guidance narrowed to $142M–$146M; adjusted gross margin guidance remains 48%–50%.

  • Year-end 2026 cash guidance is $70M, with no debt; Q3 ended with $80.7M in cash, cash equivalents, marketable securities and restricted cash.

  • Commercial initiatives are expected to begin lifting revenue in Q4, contribute more materially in 2027 and beyond, and support the unchanged 2027 cash-flow breakeven target.

  • Q4 growth drivers include Accelerator bookings, instrument placements and consumables; bookings typically convert to billings in four to six months.

  • Operating losses and negative operating cash flows are expected to continue into 2027; planned spending includes R&D, diagnostics, regulatory submissions and systems enhancements.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Quanterix earnings date

Logotype for Quanterix Corporation
Q4 20261 Mar, 2027
Quanterix
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Quanterix earnings date

Logotype for Quanterix Corporation
Q4 20261 Mar, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's proprietary platform offers high sensitivity to detect various proteins at concentrations as low as one part per trillion. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.